Gliomatosis Cerebri Latest Advances

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Journal: Expert review of anticancer therapy

Published: June 24, 2026

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Journal: Expert review of neurotherapeutics

Published: June 24, 2026

Decreased miR-1305 expression is associated with tumour invasiveness and poor prognosis in glioma patients.

Journal: The International journal of neuroscience

Published: June 23, 2026

Selective CDK2 Degradation via Noncanonical Recruitment.

Journal: Journal of medicinal chemistry

Published: June 23, 2026

Recurrence Associated IGFBP2 Promotes Malignant Progression and Epithelial Mesenchymal Transition in Glioma Cells via the AKT mTOR Pathway.

Journal: The International journal of neuroscience

Published: June 23, 2026

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 23, 2026

Choroidal coloboma masquerading as regressed retinoblastoma.

Journal: BMJ case reports

Published: June 23, 2026

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

Journal: Cell proliferation

Published: June 23, 2026

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Journal: BJC reports

Published: June 23, 2026

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Journal: Molecular biology reports

Published: June 23, 2026

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Journal: Journal of neurosurgical sciences

Published: June 23, 2026

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Gliomatosis Cerebri Latest Advances

Find the Latest Research About Gliomatosis Cerebri

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Decreased miR-1305 expression is associated with tumour invasiveness and poor prognosis in glioma patients.

Decreased miR-1305 expression is associated with tumour invasiveness and poor prognosis in glioma patients.

Selective CDK2 Degradation via Noncanonical Recruitment.

Selective CDK2 Degradation via Noncanonical Recruitment.

Recurrence Associated IGFBP2 Promotes Malignant Progression and Epithelial Mesenchymal Transition in Glioma Cells via the AKT mTOR Pathway.

Recurrence Associated IGFBP2 Promotes Malignant Progression and Epithelial Mesenchymal Transition in Glioma Cells via the AKT mTOR Pathway.

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Choroidal coloboma masquerading as regressed retinoblastoma.

Choroidal coloboma masquerading as regressed retinoblastoma.

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma.

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma.